查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1808453

製藥製造設備市場（按設備類型、技術、最終用戶和應用）—2025-2030 年全球預測

Pharmaceutical Manufacturing Equipment Market by Equipment Type, Technology, End User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計製藥製造設備市場規模到 2024 年將達到 192.2 億美元，到 2025 年將達到 205.5 億美元，到 2030 年將達到 289.1 億美元，複合年成長率為 7.03%。

主要市場統計數據
基準年2024年 192.2億美元
預計2025年 205.5億美元
預計2030年 289.1億美元
複合年成長率（%） 7.03%

製藥生產設備是藥物開發和生產的核心，能夠將複雜的製劑轉化為安全有效的治療方法。隨著產業面臨不斷變化的監管要求、日益成長的生技藥品需求以及最佳化成本和上市時間等挑戰，設備的選擇和整合已成為關鍵的策略考量。各生產設施正在投資高精度壓片壓平機、先進的層析法套件以及支援無菌製程的先進生物反應器。這些投資不僅增強了製程控制和產品質量，還提高了適應個人化醫療和小規模生產所需的營運靈活性。

近年來，細胞療法和基因療法等新型治療方法的推出進一步增強了專用發酵槽、一次性攪拌機和冷凍乾燥機的作用，使其能夠快速擴大規模。同時，傳統的固態製劑系統也在不斷發展，自動製粒機和流化床乾燥機實現了更緊密的粒徑分佈和均勻的包衣。因此，生命科學公司優先考慮整合數位監控、預測性維護和模組化架構的設備解決方案。這種整體方法使生產線能夠在不同的產品系列之間快速切換，同時保持嚴格的合規性。

展望未來，了解這些技術進步與不斷變化的市場動態和法規環境之間的關係至關重要。下文檢驗重塑製藥設備格局的變革性變化，並為評估新興趨勢的策略意義奠定基礎。

應對顛覆性的技術和監管變化，重新定義製藥設備的效率和擴充性

自動化、數位化和監管進步的整合正在推動製藥設備產業的重大變革時期。融合人工智慧的自動化平台透過即時最佳化過程參數，簡化了從膠囊填充到片劑包衣等複雜的工作流程。同時，資料驅動的品質源自於設計框架正在取代傳統的批次放行通訊協定，從而實現主動控制策略，最大限度地減少偏差並確保產品屬性的一致性。

評估2025年美國關稅對製藥設備供應鏈的多重影響

美國將於2025年實施新的關稅，這將為製藥設備的採購和部署帶來巨大的複雜性。由於進口機械和關鍵耗材的關稅上調，製造商面臨更高的資本支出要求和更長的前置作業時間。這些成本壓力迫使企業重新評估其供應商策略，並探索在免關稅管轄區內實現流體化床乾燥機、發酵槽和層析法裝置的本地化生產的方案。

透過對設備、技術、最終用戶和應用的詳細細分來揭示關鍵市場動態

深入了解市場區隔對於規劃製藥設備產業的策略重點至關重要。在考慮設備類型時，必須考慮無菌處理設備、泡殼包裝機、膠囊填充機、層析法設備、發酵槽和生物反應器、流體化床乾燥機、製粒機、液體填充機、冷凍乾燥機、攪拌機和片劑加工系統，其中片劑包衣機和壓平機片機構成一個重要的子類別。技術細分進一步區分了可重複使用設備（因其使用壽命長、成本攤銷低而受到重視）和一次性設備（其靈活性和清洗檢驗負擔較輕）。

區域市場情報重點介紹美洲、歐洲、中東和非洲地區以及亞太地區的成長動力和戰略機會

區域動態將在塑造製藥製造設備產業的發展軌跡方面發揮關鍵作用。在美洲，強大的生物製藥開發平臺和政府對國內生產的激勵措施，刺激了對一次性生物反應器、層析法系統和冷凍乾燥平台的強勁需求。北美領先的地區也在利用先進的分析和自動化技術對傳統設施進行現代化改造，以延長設備生命週期並降低營運成本。

確定領先的製藥製造設備供應商和影響行業競爭的策略性舉措

領先的設備供應商正透過有機創新、策略夥伴關係和定向收購等方式實現差異化。一些全球性公司正在透過收購利基市場無菌連接器和過濾裝置製造商來擴展其一次性產品組合，為最終用戶提供更全面的即插即用解決方案。其他公司則正在投資數位雙胞胎平台和雲端監控平台，使製程工程師無需進行實體測試即可模擬規模化生產場景並排除設備效能故障。

為行業領導者提供可行的策略和最佳實踐，以提高營運敏捷性並推動永續成長

行業領導者必須優先考慮靈活性和數位化整合，才能保持競爭力。投資模組化一次性系統可以縮短驗證週期，實現產品線之間的快速切換，並支持向個人化治療的轉變。先進的過程控制軟體與硬體升級相輔相成，可即時查看關鍵參數，使團隊能夠主動預防偏差並保持一致的輸出品質。

詳述資料收集、檢驗和分析方法的綜合研究途徑，以支持研究的可信度

本研究採用嚴謹的研究框架，結合了原始訪談、二手資料分析和量化檢驗技術。專家與製程工程師、品質保證經理和採購主管的討論，提供了關於設備性能、維護實務和策略性投資促進因素的第一手見解。這些訪談，以及對行業出版物、技術規範和監管指南的廣泛研究，確保了對市場趨勢的全面了解。

總結見解，總結關鍵發現以及對全球製藥設備相關人員的戰略意義

本執行摘要強調了先進製藥生產設備在支持穩健且高效的藥品生產方面發揮的關鍵作用。探索從自動化和一次性技術到貿易政策影響的變革趨勢，可以幫助產業相關人員更好地應對日益複雜的市場環境。細分分析揭示了按設備類型、技術偏好、最終用戶類別和應用領域分類的不同需求概況，凸顯了製定客製化策略的必要性。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 製藥生產中對一次性技術的需求不斷增加，以降低污染風險
  • 傳統製造流程的日益普及正在改變全球製藥設備產業的格局
  • 將物聯網 (IoT) 整合到製藥製造設備中，以實現即時監控和控制
  • 越來越關注能源​​效率和永續性設計
  • 利用人工智慧和機器學習最佳化製藥生產工作流程
  • 引進先進的自動化技術，提高製藥設備效率與精度
  • 開發可客製化、模組化的製藥生產設備，滿足多樣化的生產需求
  • 滅菌技術的進步提高了藥品生產的安全標準
  • 生物技術和個人化醫療的擴展將推動製造設備的創新
  • 法規遵從性影響製藥製造設備標準與能力的演變

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

第 8 章：製藥製造設備市場（按設備類型）

  • 無菌加工設備
  • 泡殼包裝機
  • 膠囊填充設備
  • 層析法設備
  • 發酵槽和生物反應器
  • 流體化流體化床乾燥機
  • 製粒機
  • 液體填充機
  • 冷凍乾燥設備
  • 攪拌機
  • 片劑加工設備
    • 片劑包衣機
    • 壓片機

第9章：製藥製造設備市場（依技術）

  • 可重複使用設備
  • 免洗設備

第 10 章：製藥製造設備市場（依最終用戶）

  • 契約製造組織
  • 製藥公司
  • 研究和學術機構
  • 研究所

第 11 章製藥製造設備市場（按應用）

  • 無菌灌裝
  • 生物製藥製造
  • 口服液體製造
  • 腸外生產
  • 固態劑型生產

第 12 章：美洲製藥製造設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

第 13 章：歐洲、中東和非洲製藥製造設備市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

第14章：亞太製藥製造設備市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第15章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • ACG Pvt. Ltd.
    • ACIC Pharmaceuticals Inc.
    • Alfa Laval AB
    • Ambica Pharma Machines Pvt. Ltd.
    • GEA Group Aktiengesellschaft
    • Glatt GmbH
    • IDEX Corporation
    • IMA Group
    • Jinhu Ginhong Machinery Co., Ltd.
    • Komachine Inc.
    • Korber AG
    • Lee Industries
    • Maquinaria Industrial Dara, SL
    • Marchesini Group SpA
    • MG2 srl
    • Niverplast BV
    • Paul Mueller Company
    • Romaco Group
    • Shinva Medical Instrument Co., Ltd.
    • Solvay SA
    • Syntegon Technology GmbH
    • Thermo Fisher Scientific Inc.
    • UNITED PHARMATEK LLC

第16章 研究人工智慧

第17章 研究統計

第18章 研究聯絡人

第19章 研究報導

第20章 附錄

Product Code: MRR-961BA04A2E92

The Pharmaceutical Manufacturing Equipment Market was valued at USD 19.22 billion in 2024 and is projected to grow to USD 20.55 billion in 2025, with a CAGR of 7.03%, reaching USD 28.91 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 19.22 billion
Estimated Year [2025] USD 20.55 billion
Forecast Year [2030] USD 28.91 billion
CAGR (%) 7.03%

Pharmaceutical manufacturing equipment sits at the heart of drug development and production, enabling the translation of complex formulations into safe, effective therapies. As the industry contends with evolving regulatory requirements, rising demand for biologics, and the imperative to optimize cost and time to market, equipment selection and integration have become critical strategic considerations. Facilities are investing in high-precision tablet presses, state-of-the-art chromatography suites, and advanced bioreactors that support aseptic processing. These investments not only enhance process control and product quality but also foster the operational flexibility needed to address personalized medicine and small-batch production.

In recent years, the entry of novel therapeutic modalities such as cell and gene therapies has further elevated the role of specialized fermenters, single-use mixers, and lyophilizers in enabling rapid scale-up. Meanwhile, traditional solid dosage systems have continued to evolve, featuring automated granulators and fluid bed dryers that deliver tighter particle size distribution and uniform coating. Consequently, life science companies are prioritizing equipment solutions that integrate digital monitoring, predictive maintenance, and modular architectures. This holistic approach ensures that manufacturing lines can pivot swiftly between diverse product portfolios while maintaining rigorous compliance.

Looking ahead, understanding how these technological advancements intersect with shifting market dynamics and regulatory environments will be essential. The following section examines the transformative shifts reshaping the pharmaceutical equipment landscape and sets the stage for assessing the strategic implications of emerging trends.

Navigating Disruptive Technological and Regulatory Transformations Redefining Pharmaceutical Equipment Efficiency and Scalability

The pharmaceutical equipment landscape is undergoing seismic transformation as advances in automation, digitalization, and regulatory expectations converge. Automation platforms embedded with artificial intelligence are streamlining complex workflows, from capsule filling to tablet coating, by optimizing process parameters in real time. Concurrently, data-driven quality by design frameworks are replacing traditional batch release protocols, enabling proactive control strategies that minimize deviations and ensure consistent product attributes.

Single-use technologies have moved beyond niche applications to become mainstream, particularly in biopharmaceutical manufacturing environments where contamination risks and cleaning validation costs drive demand for disposable systems. This shift has challenged equipment manufacturers to expand their portfolios to include sterile connectors, prevalidated assemblies, and modular fluid handling units. In parallel, continuous processing architectures are gaining traction for both small molecule and biologic production, promising reduced footprint, lower energy consumption, and improved yield stability.

Regulatory agencies across key markets are also reshaping the landscape. Recent guidance has emphasized process analytical technologies, real-time release testing, and lifecycle management practices, compelling equipment suppliers and end users to collaborate early in development. Supply chain resilience has emerged as another critical axis of transformation, with firms diversifying component sourcing and exploring nearshoring strategies to mitigate geopolitical uncertainties. Taken together, these disruptive forces are redefining efficiency, scalability, and risk management in pharmaceutical manufacturing.

Assessing the Multifaceted Consequences of United States Tariffs on Pharmaceutical Manufacturing Equipment Supply Chains in 2025

The implementation of new United States tariffs in 2025 has introduced significant complexity to the procurement and deployment of pharmaceutical manufacturing equipment. As duties increase on imported machinery and critical consumables, manufacturers have encountered rising capital expenditure requirements and extended lead times. These cost pressures have prompted organizations to reassess supplier strategies, exploring options to localize production of fluid bed dryers, fermenters, and chromatography units in tariff-free jurisdictions.

The ramifications extend beyond direct cost increases. Equipment vendors facing higher import duties are recalibrating pricing models and, in some cases, shifting inventory buffers to domestic warehouses. End users have responded by grouping orders into larger shipments to dilute tariff impacts or renegotiating long-term service contracts to secure fixed pricing. Meanwhile, the threat of further trade restrictions has accelerated interest in distributed manufacturing networks, where modular tablet processing and liquid filling systems can be deployed closer to end markets.

Despite these challenges, strategic adaptation has unlocked opportunities for equipment innovators. Firms that have invested in local engineering capabilities and decentralized assembly facilities are better positioned to maintain delivery timelines and preserve margins. Moreover, the tariffs have intensified collaboration between manufacturers and financial services providers, leading to creative leasing structures and equipment-as-a-service offerings that defer upfront capital outlay. Ultimately, navigating the 2025 tariff environment will demand agility, foresight, and the willingness to embrace alternative procurement models.

Uncovering Critical Market Dynamics through Detailed Equipment, Technology, End User, and Application Segmentation Insights

A nuanced understanding of market segmentation is essential to charting strategic priorities within the pharmaceutical equipment sector. When examining equipment types, one must consider aseptic processing equipment, blister packaging machines, capsule filling equipment, chromatography instruments, fermenters and bioreactors, fluid bed dryers, granulators, liquid filling machines, lyophilizers, mixers, and tablet processing systems, with tablet coating machines and tablet presses forming critical subcategories. Technology segmentation further distinguishes between reusable equipment-valued for its longevity and cost amortization-and single use equipment, which provides flexibility and reduced cleaning validation burdens.

End users span contract manufacturing organizations that deliver turnkey production services, pharmaceutical companies driving in-house manufacturing, research and academic institutes fostering early-stage innovation, and specialized research institutes focusing on advanced therapeutics. Application segmentation highlights the breadth of use cases, extending from aseptic filling operations to biopharmaceutical manufacturing, oral liquid production, parenteral processing, and solid dosage form creation. This layered segmentation framework reveals that demand drivers vary significantly by category: bioreactor and single-use mixer uptake is strongest in the biopharma segment, whereas granulators and tablet presses remain mainstays for solid dose players.

By aligning product development roadmaps with these segment dynamics, equipment providers can prioritize feature sets and geographic roll-out strategies that resonate most powerfully within each niche. Moreover, end users can tailor capital investments and maintenance programs according to the risk profile and regulatory intensity associated with their core applications.

Regional Market Intelligence Illuminating Growth Drivers and Strategic Opportunities across the Americas, EMEA, and Asia-Pacific Landscapes

Regional dynamics play a defining role in shaping the pharmaceutical manufacturing equipment sector's trajectory. In the Americas, strong biopharmaceutical R&D pipelines and government incentives for domestic production have stimulated robust demand for single use bioreactors, chromatography systems, and lyophilization platforms. Key hubs in North America are also leveraging advanced analytics and automation to modernize legacy facilities, thereby extending equipment lifecycles and reducing operational expenditures.

The Europe, Middle East & Africa region exhibits a more diverse set of drivers. Western European markets continue to lead in continuous processing adoption and integration of industry 4.0 solutions, supported by stringent regulatory regimes that emphasize quality by design. In contrast, emerging markets across the Middle East and Africa are investing in blister packaging and liquid filling lines to meet growing generic drug demand, with local regulatory bodies gradually strengthening manufacturing standards to align with global best practices.

Asia-Pacific stands out for its rapid capacity additions and cost-competitive manufacturing base. Countries such as India and China are scaling up granulators, tablet presses, and fluid bed dryers to serve both domestic and export markets. Simultaneously, regional governments are offering incentives for advanced bioreactor installations and funding collaborative centers of excellence. Connectivity initiatives are also fostering cross-border partnerships that accelerate technology transfer and localize after-sales support.

Identifying Leading Pharmaceutical Manufacturing Equipment Providers and Their Strategic Initiatives Shaping Industry Competitiveness

Leading equipment providers are differentiating themselves through a mix of organic innovation, strategic partnerships, and targeted acquisitions. Several global firms have expanded their single-use portfolio by acquiring niche manufacturers of sterile connectors and filtration units, thereby offering end users more comprehensive plug-and-play solutions. Others have invested in digital twins and cloud-enabled monitoring platforms, allowing process engineers to simulate scale-up scenarios and troubleshoot equipment performance without physical trials.

Collaborations between technology specialists and research institutions are also on the rise, resulting in co-developed chromatography resins and advanced sensor arrays that deliver tighter process control. Meanwhile, certain legacy suppliers have focused on modular skid-based systems, enabling contract manufacturers to rapidly configure production lines for new molecule launches. Service differentiation has become equally important, with firms offering predictive maintenance contracts and embedded remote diagnostics that proactively address equipment health issues.

Competition is further intensified by emerging players from adjacent industries, such as semiconductor equipment vendors entering the bioprocessing space with precision fluidics and contamination control expertise. This dynamic landscape underscores the importance of agility, with top performers continually refining their go-to-market strategies and leveraging cross-segment insights to anticipate customer needs.

Actionable Strategies and Best Practices for Industry Leaders to Enhance Operational Agility and Drive Sustainable Growth

Industry leaders should prioritize flexibility and digital integration to remain competitive. Investing in modular, single-use systems can reduce validation cycles and enable rapid changeover between product lines, supporting a shift toward personalized therapies. Complementing hardware upgrades with advanced process control software will provide real-time visibility into critical parameters, allowing teams to preempt deviations and maintain consistent output quality.

Diversifying supply chains is equally essential in the current geopolitical climate. Establishing partnerships with regional equipment assemblers and adopting equipment-as-a-service models can mitigate exposure to tariffs and logistical disruptions. Additionally, engaging early with regulatory authorities to align on process analytical technology roadmaps can streamline approvals and reduce post-approval modifications.

Finally, fostering cross-functional collaboration between R&D, engineering, and operations teams will accelerate technology adoption and drive continuous improvement. By embedding a culture of innovation, organizations can harness data insights to refine workflows, optimize utility consumption, and scale capacity efficiently. This holistic approach balances cost discipline with agility, positioning firms to capitalize on emerging therapeutic trends and evolving market demands.

Comprehensive Research Approach Detailing Data Collection, Validation, and Analytical Methods Underpinning Study Credibility

This study was developed through a rigorous research framework combining primary interviews, secondary data analysis, and quantitative validation techniques. Expert discussions with process engineers, quality assurance managers, and procurement directors provided firsthand insights into equipment performance, maintenance practices, and strategic investment drivers. Supplementing these interviews, an extensive review of industry publications, technical specifications, and regulatory guidelines ensured a comprehensive understanding of market trends.

Data triangulation methods were applied to corroborate findings across multiple sources. Equipment shipment records, patent filings, and academic research outputs were cross-referenced to confirm technology adoption timelines. Furthermore, a structured scoring model evaluated vendor capabilities against criteria such as innovation pipeline strength, service network coverage, and digital platform maturity. This model enabled objective comparisons and highlighted areas of competitive differentiation.

Throughout the process, quality controls were maintained via iterative peer reviews and validation checkpoints. Analysts continuously refined assumptions, updated contextual factors, and solicited feedback from advisory board members with deep domain expertise. The result is a robust and transparent methodology that underpins the study's strategic recommendations and ensures actionable intelligence for decision makers.

Conclusive Insights Summarizing Key Findings and Strategic Implications for Global Pharmaceutical Equipment Stakeholders

This executive summary has highlighted the critical role of advanced pharmaceutical manufacturing equipment in supporting robust and efficient drug production. By exploring transformative trends-from automation and single-use technologies to trade policy impacts-industry stakeholders can better navigate an increasingly complex landscape. Segmentation analysis has illuminated distinct demand profiles across equipment types, technology preferences, end-user categories, and application areas, underscoring the need for tailored strategies.

Regional insights reveal that the Americas, EMEA, and Asia-Pacific each present unique growth drivers and challenges, whether it be biopharma innovation clusters, regulatory harmonization efforts, or cost-competitive capacity expansions. Competitive intelligence underscores the importance of strategic partnerships, digital service offerings, and modular system architectures in differentiating vendor propositions. Finally, actionable recommendations emphasize flexibility, supply chain diversification, and data-driven process control as key enablers of sustainable growth.

Armed with these findings, equipment providers and end users alike can make informed decisions that balance operational efficiency with technological agility. Embracing a holistic approach to equipment strategy will be essential to unlocking new opportunities, managing risk, and achieving long-term success in the evolving pharmaceutical manufacturing ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Growing demand for single-use technologies in pharmaceutical production to reduce contamination risks
  • 5.2. Rising adoption of continuous manufacturing processes transforming pharmaceutical equipment landscape globally
  • 5.3. Integration of Internet of Things (IoT) in pharmaceutical manufacturing equipment for real-time monitoring and control
  • 5.4. Increasing focus on energy-efficient and sustainable pharmaceutical manufacturing equipment designs
  • 5.5. Utilization of artificial intelligence and machine learning to optimize pharmaceutical manufacturing workflows
  • 5.6. Implementation of advanced automation technologies in pharmaceutical manufacturing equipment to enhance efficiency and precision
  • 5.7. Development of customizable and modular pharmaceutical manufacturing equipment to meet diverse production needs
  • 5.8. Advancements in sterilization technologies improving safety standards in pharmaceutical manufacturing
  • 5.9. Expansion of biotechnology and personalized medicine driving innovation in manufacturing equipment
  • 5.10. Regulatory compliance shaping the evolution of pharmaceutical manufacturing equipment standards and features

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Pharmaceutical Manufacturing Equipment Market, by Equipment Type

  • 8.1. Introduction
  • 8.2. Aseptic Processing Equipment
  • 8.3. Blister Packaging Machines
  • 8.4. Capsule Filling Equipment
  • 8.5. Chromatography Equipment
  • 8.6. Fermenters & Bioreactors
  • 8.7. Fluid Bed Dryers
  • 8.8. Granulators
  • 8.9. Liquid Filling Machines
  • 8.10. Lyophilizers
  • 8.11. Mixers
  • 8.12. Tablet Processing Equipment
    • 8.12.1. Tablet Coating Machine
    • 8.12.2. Tablet Press

9. Pharmaceutical Manufacturing Equipment Market, by Technology

  • 9.1. Introduction
  • 9.2. Reusable Equipment
  • 9.3. Single Use Equipment

10. Pharmaceutical Manufacturing Equipment Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Manufacturing Organizations
  • 10.3. Pharmaceutical Companies
  • 10.4. Research & Academic Institutes
  • 10.5. Research Institutes

11. Pharmaceutical Manufacturing Equipment Market, by Application

  • 11.1. Introduction
  • 11.2. Aseptic Filling
  • 11.3. Biopharmaceutical Manufacturing
  • 11.4. Oral Liquid Manufacturing
  • 11.5. Parenteral Manufacturing
  • 11.6. Solid Dosage Manufacturing

12. Americas Pharmaceutical Manufacturing Equipment Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Pharmaceutical Manufacturing Equipment Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Pharmaceutical Manufacturing Equipment Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. ACG Pvt. Ltd.
    • 15.3.2. ACIC Pharmaceuticals Inc.
    • 15.3.3. Alfa Laval AB
    • 15.3.4. Ambica Pharma Machines Pvt. Ltd.
    • 15.3.5. GEA Group Aktiengesellschaft
    • 15.3.6. Glatt GmbH
    • 15.3.7. IDEX Corporation
    • 15.3.8. IMA Group
    • 15.3.9. Jinhu Ginhong Machinery Co., Ltd.
    • 15.3.10. Komachine Inc.
    • 15.3.11. Korber AG
    • 15.3.12. Lee Industries
    • 15.3.13. Maquinaria Industrial Dara, S.L.
    • 15.3.14. Marchesini Group S.p.A.
    • 15.3.15. MG2 s.r.l.
    • 15.3.16. Niverplast B.V.
    • 15.3.17. Paul Mueller Company
    • 15.3.18. Romaco Group
    • 15.3.19. Shinva Medical Instrument Co., Ltd.
    • 15.3.20. Solvay S.A.
    • 15.3.21. Syntegon Technology GmbH
    • 15.3.22. Thermo Fisher Scientific Inc.
    • 15.3.23. UNITED PHARMATEK LLC

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCHAI
  • FIGURE 24. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCHSTATISTICS
  • FIGURE 25. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCHCONTACTS
  • FIGURE 26. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC PROCESSING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC PROCESSING EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CAPSULE FILLING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CAPSULE FILLING EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CHROMATOGRAPHY EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FERMENTERS & BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FERMENTERS & BIOREACTORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FLUID BED DRYERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY FLUID BED DRYERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GRANULATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY GRANULATORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LIQUID FILLING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LIQUID FILLING MACHINES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY LYOPHILIZERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY MIXERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY MIXERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET COATING MACHINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET COATING MACHINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PRESS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PRESS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REUSABLE EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY REUSABLE EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SINGLE USE EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SINGLE USE EQUIPMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ASEPTIC FILLING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ORAL LIQUID MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY ORAL LIQUID MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PARENTERAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY PARENTERAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SOLID DOSAGE MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY SOLID DOSAGE MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 69. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 73. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 75. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 76. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 77. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. AMERICAS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 79. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 81. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 82. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 83. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 84. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 85. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 86. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 87. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 88. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 89. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 90. UNITED STATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 91. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 93. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 94. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 95. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 96. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 97. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 98. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 99. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. CANADA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 101. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 103. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 104. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 105. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 106. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 107. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 108. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 109. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 110. MEXICO PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 111. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 113. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 114. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 115. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 116. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 117. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 119. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. BRAZIL PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 121. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 122. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 123. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 124. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 125. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 126. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 127. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 128. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 129. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 130. ARGENTINA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 146. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 148. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 153. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 155. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 156. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 157. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 159. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 161. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. GERMANY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 163. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 165. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 166. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 167. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 169. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 170. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 171. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. FRANCE PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 173. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 175. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 176. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 177. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 179. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 181. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. RUSSIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 183. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 186. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 187. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 189. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 191. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. ITALY PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 193. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 194. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 195. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 196. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 197. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 199. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 201. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. SPAIN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 203. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 205. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 206. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 207. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 209. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 211. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 213. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 216. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 217. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 219. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 221. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 223. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 225. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 226. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 227. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 229. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 231. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 233. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 235. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 236. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 237. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 239. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 240. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 241. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. DENMARK PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 243. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 245. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 246. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 247. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 249. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 251. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. NETHERLANDS PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 253. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 255. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 256. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 257. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 259. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 261. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. QATAR PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 263. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 266. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 267. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 269. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 270. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 271. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. FINLAND PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 273. SWEDEN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. SWEDEN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY EQUIPMENT TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. SWEDEN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 276. SWEDEN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TABLET PROCESSING EQUIPMENT, 2025-2030 (USD MILLION)
  • TABLE 277. SWEDEN PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. SWEDEN PHARMACEUTICAL MANUFACTURING EQUIPMENT